Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VINCOV-19
- Development stage
- Unknown
- Lead developer
- VINS Bio Products
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
VINCOV-19 is an equine-derived polyclonal antibody therapeutic developed by Vins Bioproducts in collaboration with the Centre for Cellular and Molecular Biology (CCMB) and the University of Hyderabad. It consists of highly purified F(ab')2 antibody fragments obtained from horses immunized with SARS-CoV-2 viral antigens. As a form of passive immunotherapy, VINCOV-19 works by binding to and neutralizing the SARS-CoV-2 virus, effectively blocking its internalization into human lung cells. The therapeutic has shown efficacy against multiple variants, including Omicron, and is indicated for the treatment of moderate COVID-19 in adults aged 18 to 65.
- Brand names
- VINCOV-19VINCOV19VINCOV 19
- Other names
- SARS-CoV-2-equine F(ab')2 antibody fragment
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on VINCOV-19.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VINCOV-19.